Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan and Sildenafil in Eisenmenger Syndrome
NCT00303004Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Mar 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sildenafil in Eisenmenger syndrome (2 arms), sponsored by Rigshospitalet. Primary endpoint: 6 Minutes Walking Distance. Started Mar 2006; status: completed.
02
Drugs
sildenafil
03
Conditions
Eisenmenger syndrome
Beyond the preview
Go deeper on NCT00303004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303004.